Fungus Makes Mosquitoes Much More Likely to Become Infected With Malaria


Researchers at the Johns Hopkins Bloomberg School of Public Health have identified a fungus that compromises the immune system of mosquitoes, making them more susceptible to infection with the parasite that causes malaria. Because environmental microorganisms can vary greatly from region to region, the researchers say the findings may help explain variations in the prevalence of malaria in different geographic areas.

Mosquitoes, like humans, are continuously exposed to a variety of microbes in their environment, and these bacteria and fungi can influence the health of mosquitoes in many ways. Malaria researchers have in the past identified microbes that block the Anopheles mosquito from being infected by the parasite that causes malaria, but this is the first time they have found a microorganism that instead appears to make the mosquito more likely to become infected with – and then spread – malaria. The findings are published online September 28 in the journal Scientific Reports.

“This very common, naturally occurring fungus may have a significant impact on malaria transmission: It doesn’t kill the mosquitoes, it doesn’t make them sick, it just makes them more likely to become infected and thereby to spread the disease,” says the study’s leader George Dimopoulos, PhD, MBA, a professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School and a deputy director of its Johns Hopkins Malaria Research Institute. “While this fungus is unlikely to be helpful as part of a malaria control strategy, our finding significantly advances our knowledge of the different factors that influence the transmission of malaria.”

Malaria is caused when Anopheles mosquitoes are infected with the Plasmodium parasite and go on to bite and infect healthy humans. Mosquitoes become infected when they bite and feed on humans who are infected with the Plasmodium parasite.

For their study, Dimopoulos and his team isolated the Penicillium chrysogenum fungus – a member of the same family of fungi that gives us the antibiotic penicillin – from the gut of field-caught Anopheles mosquitoes. They determined that its presence made the mosquitoes much more susceptible to being infected by the parasite that causes malaria. The fungus, they found, was compromising the immune system of the mosquitoes, allowing the malaria parasite to more easily infect them.

According to the World Health Organization, there were roughly 214 million malaria cases and an estimated 438,000 malaria deaths around the world in 2015. Sub-Saharan Africa continues to carry a disproportionately high share of the global malaria burden. In 2015, the region was home to 89 percent of malaria cases and 91 percent of malaria deaths.

Scientists are still working to find an effective vaccine against malaria. Other strategies have focused on preventing mosquito bites that cause malaria infections, spraying insecticides to control the quantity of malaria-carrying mosquitoes and developing ways to genetically modify mosquitoes to make them immune from the malaria parasite.

Dimopoulos says the Penicillium chrysogenum fungus has not been studied in terms of mosquito biology. He and his team had hoped the fungus would act like several other bacteria that researchers have identified that actually block mosquitoes from becoming infected with the parasite that causes malaria. Even though this fungus actually appears to worsen infections, it can still help researchers in their fight against malaria.

“We have questions we hope this finding will help us to answer including why do we have increased transmission of malaria in some areas and not others when the presence of mosquitoes is the same,” he says. “This gives us another piece of the complicated malaria puzzle.”

Dimopoulos says research in the field is necessary to see if the fungi affect mosquitoes in the same way in nature as they do in the laboratory.

“A natural Anopheles-associated Penicillium chrysogenum enhances mosquito susceptibility to Plasmodium infection” was written by Yesseinia I. Angleró-Rodríguez, Benjamin J. Blumberg, Yuemei Dong, Simone L. Sandiford, Andrew Pike, April M. Clayton and George Dimopoulos.

This work was supported by the National Institutes of Health’s National Institute of Allergy and Infectious Disease (R01AI061576, R01AI101431 and R01AI081877), a Johns Hopkins Malaria Research Institute pre-doctoral fellowship and a UNCF-Merck Science Initiative Graduate Research Fellowship.

Source: Johns Hopkins Bloomberg School of Public Health 

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content